Regulatory Status: FDA, WADA & Compounded Peptides
What "not FDA-approved" actually means, the compounding risk list, and strict-liability anti-doping rules.
Approval is a package, not a stamp
FDA approval means a compound passed adequately powered human trials for a defined indication, with validated dosing, manufacturing oversight, and ongoing adverse-event surveillance. "Not approved" removes the entire package — there is no validated dose to look up and no oversight of what is actually in the vial.
The compounding risk list
Several popular research peptides — including BPC-157 and CJC-1295 — appear among bulk drug substances the FDA has flagged as presenting significant safety risks when compounded. Sellers labeling these "research chemicals, not for human consumption" are using a legal posture, not a safety judgment.
Athletes: strict liability
- GH secretagogues and repair peptides such as TB-500 sit on WADA prohibited lists — many at all times, not just in competition.
- Anti-doping violations are strict liability: a positive test is a violation regardless of intent or product labeling.
- Semaglutide illustrates the other side: real approval, defined indications, prescription access, and FDA warnings aimed specifically at compounded copies.
Knowledge check
Answer 5 questions — 4 correct passes and earns 50 points.
1. "Not FDA-approved" most precisely means:
2. BPC-157 appearing on the FDA compounding risk list means:
3. "Research chemical — not for human consumption" labels primarily function as:
4. A tested athlete uses a supplement contaminated with a prohibited secretagogue and tests positive. Under strict liability:
5. Which compound pairs real FDA approval with FDA warnings about compounded versions?
Points are credited once per module, up to 5 point-earning completions per calendar month. Back to all modules